Thema
Journal Article
38
Multiple sclerosis
17
Research Support, Non-U.S. Gov't
13
Randomized Controlled Trial
8
Dimethyl fumarate
7
multiple sclerosis
7
Fingolimod
6
Teriflunomide
6
Antibodies, Monoclonal, Humanized
5
Review
5
Healthcare costs
4
Healthcare resource utilization
4
Immunosuppressive Agents
4
Natalizumab
4
Relapse
4
Severity
4
Absenteeism
3
Adherence
3
Clinical Trial, Phase III
3
Dimethyl Fumarate
3
Discontinuation
3
FO2303MNI2
3
Meta-analysis
3
Persistence
3
Presenteeism
3
Real-world
3
Relapsing-remitting multiple sclerosis
3
Work impairment
3
disease-modifying therapy
3
570
2
A10SJL62JY
2
Alemtuzumab
2
Biology
2
Biomarkers
2
COVID-19 Vaccines
2
Case Reports
2
Cognition
2
Comparative effectiveness
2
Disease-modifying therapy
2
Fingolimod Hydrochloride
2
G926EC510T
2
Glatiramer acetate
2
Interferon beta
2
M95KG522R0
2
MS PATHS
2
Ofatumumab
2
natalizumab
2
ocrelizumab
2
ofatumumab
2
quality of life
2
mehr ...